Copyright Reports & Markets. All rights reserved.

Global Human Prothrombin Complex Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Prothrombin Complex Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 500 IU/Vial
    • 1.3.3 600 IU/Vial
    • 1.3.4 1000 IU/Vial
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Prothrombin Complex Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hemophilia B
    • 1.4.3 Vitamin K Deficiency
    • 1.4.4 Others
  • 1.5 Global Human Prothrombin Complex Market Size & Forecast
    • 1.5.1 Global Human Prothrombin Complex Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Human Prothrombin Complex Sales Quantity (2020-2031)
    • 1.5.3 Global Human Prothrombin Complex Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Takeda
    • 2.1.1 Takeda Details
    • 2.1.2 Takeda Major Business
    • 2.1.3 Takeda Human Prothrombin Complex Product and Services
    • 2.1.4 Takeda Human Prothrombin Complex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Takeda Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Human Prothrombin Complex Product and Services
    • 2.2.4 CSL Human Prothrombin Complex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 Grifols
    • 2.3.1 Grifols Details
    • 2.3.2 Grifols Major Business
    • 2.3.3 Grifols Human Prothrombin Complex Product and Services
    • 2.3.4 Grifols Human Prothrombin Complex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Grifols Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Human Prothrombin Complex Product and Services
    • 2.4.4 Octapharma Human Prothrombin Complex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 Hualan Biological
    • 2.5.1 Hualan Biological Details
    • 2.5.2 Hualan Biological Major Business
    • 2.5.3 Hualan Biological Human Prothrombin Complex Product and Services
    • 2.5.4 Hualan Biological Human Prothrombin Complex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hualan Biological Recent Developments/Updates
  • 2.6 Meheco Xinxing Pharma
    • 2.6.1 Meheco Xinxing Pharma Details
    • 2.6.2 Meheco Xinxing Pharma Major Business
    • 2.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Product and Services
    • 2.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Meheco Xinxing Pharma Recent Developments/Updates

3 Competitive Environment: Human Prothrombin Complex by Manufacturer

  • 3.1 Global Human Prothrombin Complex Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Human Prothrombin Complex Revenue by Manufacturer (2020-2025)
  • 3.3 Global Human Prothrombin Complex Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Human Prothrombin Complex by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Human Prothrombin Complex Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Human Prothrombin Complex Manufacturer Market Share in 2024
  • 3.5 Human Prothrombin Complex Market: Overall Company Footprint Analysis
    • 3.5.1 Human Prothrombin Complex Market: Region Footprint
    • 3.5.2 Human Prothrombin Complex Market: Company Product Type Footprint
    • 3.5.3 Human Prothrombin Complex Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Prothrombin Complex Market Size by Region
    • 4.1.1 Global Human Prothrombin Complex Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Human Prothrombin Complex Consumption Value by Region (2020-2031)
    • 4.1.3 Global Human Prothrombin Complex Average Price by Region (2020-2031)
  • 4.2 North America Human Prothrombin Complex Consumption Value (2020-2031)
  • 4.3 Europe Human Prothrombin Complex Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Human Prothrombin Complex Consumption Value (2020-2031)
  • 4.5 South America Human Prothrombin Complex Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Human Prothrombin Complex Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Human Prothrombin Complex Sales Quantity by Type (2020-2031)
  • 5.2 Global Human Prothrombin Complex Consumption Value by Type (2020-2031)
  • 5.3 Global Human Prothrombin Complex Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Human Prothrombin Complex Sales Quantity by Application (2020-2031)
  • 6.2 Global Human Prothrombin Complex Consumption Value by Application (2020-2031)
  • 6.3 Global Human Prothrombin Complex Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Human Prothrombin Complex Sales Quantity by Type (2020-2031)
  • 7.2 North America Human Prothrombin Complex Sales Quantity by Application (2020-2031)
  • 7.3 North America Human Prothrombin Complex Market Size by Country
    • 7.3.1 North America Human Prothrombin Complex Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Human Prothrombin Complex Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Human Prothrombin Complex Sales Quantity by Type (2020-2031)
  • 8.2 Europe Human Prothrombin Complex Sales Quantity by Application (2020-2031)
  • 8.3 Europe Human Prothrombin Complex Market Size by Country
    • 8.3.1 Europe Human Prothrombin Complex Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Human Prothrombin Complex Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Prothrombin Complex Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Human Prothrombin Complex Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Human Prothrombin Complex Market Size by Region
    • 9.3.1 Asia-Pacific Human Prothrombin Complex Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Human Prothrombin Complex Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Human Prothrombin Complex Sales Quantity by Type (2020-2031)
  • 10.2 South America Human Prothrombin Complex Sales Quantity by Application (2020-2031)
  • 10.3 South America Human Prothrombin Complex Market Size by Country
    • 10.3.1 South America Human Prothrombin Complex Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Human Prothrombin Complex Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Prothrombin Complex Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Human Prothrombin Complex Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Human Prothrombin Complex Market Size by Country
    • 11.3.1 Middle East & Africa Human Prothrombin Complex Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Human Prothrombin Complex Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Human Prothrombin Complex Market Drivers
  • 12.2 Human Prothrombin Complex Market Restraints
  • 12.3 Human Prothrombin Complex Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Prothrombin Complex and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Prothrombin Complex
  • 13.3 Human Prothrombin Complex Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Prothrombin Complex Typical Distributors
  • 14.3 Human Prothrombin Complex Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Prothrombin Complex market size was valued at US$ 2025 million in 2024 and is forecast to a readjusted size of USD 4309 million by 2031 with a CAGR of 11.5% during review period.
    Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
    Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
    North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
    In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
    This report is a detailed and comprehensive analysis for global Human Prothrombin Complex market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Prothrombin Complex market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (M USD/Unit), 2020-2031
    Global Human Prothrombin Complex market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (M USD/Unit), 2020-2031
    Global Human Prothrombin Complex market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (M USD/Unit), 2020-2031
    Global Human Prothrombin Complex market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (M USD/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Prothrombin Complex
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Prothrombin Complex market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Prothrombin Complex market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    500 IU/Vial
    600 IU/Vial
    1000 IU/Vial
    Others
    Market segment by Application
    Hemophilia B
    Vitamin K Deficiency
    Others
    Major players covered
    Takeda
    CSL
    Grifols
    Octapharma
    Hualan Biological
    Meheco Xinxing Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Prothrombin Complex product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Prothrombin Complex, with price, sales quantity, revenue, and global market share of Human Prothrombin Complex from 2020 to 2025.
    Chapter 3, the Human Prothrombin Complex competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Prothrombin Complex breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Prothrombin Complex market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Prothrombin Complex.
    Chapter 14 and 15, to describe Human Prothrombin Complex sales channel, distributors, customers, research findings and conclusion.

    Buy now